- Potential benefitMay raise public awareness, potentially increasing screening uptake and earlier cancer detection.
- Potential benefitCould reduce colorectal cancer mortality over time if screening and follow-up care increase.
- Potential benefitMight channel nonprofit, public health, and provider attention to coordinated outreach and education.
Supporting the designation of March 2025 as National Colorectal Cancer Awareness Month.
Referred to the House Committee on Oversight and Government Reform.
This resolution is a simple resolution passed by the House that expresses support for naming March 2025 as National Colorectal Cancer Awareness Month. It does not create new law, change federal programs, or require the President's signature. In practice it signals the House's support and encourages public awareness and educational activities but has no binding legal effect.
This House resolution supports designating March 2025 as National Colorectal Cancer Awareness Month and encourages awareness and educational activities about colorectal cancer prevention and screening.
The text highlights screening's preventive value, survival statistics, and current gaps in screening rates.
Nonbinding House resolution is easy to adopt in the House but does not create law; becoming statutory law is unlikely absent separate legislation.
Relative to its intended legislative type, this bill is a straightforward commemorative House resolution that clearly states the problem and purpose (awareness of colorectal cancer) and performs the customary functions of such resolutions: express support and encourage observance. It does not include operational, fiscal, or legal changes, which is consistent with its symbolic nature.
Progressives emphasize screening access and addressing disparities
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenResolution is symbolic and does not provide funding, legal mandates, or new programs.
- Potential burdenLikely limited measurable effect on screening without targeted funding and outreach to low‑uptake groups.
- Local governmentsIncreased short‑term demand for screening could strain local capacity where services are limited.
Why the argument around this bill splits.
Progressives emphasize screening access and addressing disparities
Strongly supportive.
Views the resolution as a useful, low-cost public health measure to promote prevention, early detection, and reduce mortality.
Would like it to prompt concrete action to improve screening access and address disparities, though the resolution contains no funding commitments.
Generally supportive.
Sees a mostly harmless, consensus-building public-health resolution that encourages screening and education.
Prefers clarity that this is non-binding, cost-neutral, and that any follow-up programs be evidence-based and fiscally responsible.
Supportive but cautious.
Comfortable with a symbolic awareness resolution; prefers minimal federal expansion or mandates.
Likely to endorse personal responsibility and private-sector or community-based screening outreach over new federal spending.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Nonbinding House resolution is easy to adopt in the House but does not create law; becoming statutory law is unlikely absent separate legislation.
- Whether House leadership will schedule floor consideration
- If a companion or similar Senate resolution will be introduced
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize screening access and addressing disparities
Nonbinding House resolution is easy to adopt in the House but does not create law; becoming statutory law is unlikely absent separate legis…
Relative to its intended legislative type, this bill is a straightforward commemorative House resolution that clearly states the problem and purpose (awareness of colorectal cancer) and performs the customary functions…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.